Home

Home

article image

Screenings beneficial in common tuberculosis areas

In areas of the UK where tuberculosis has a high prevalence, screenings could increase diagnosis both of active and latent forms of the disease and therefore could help prevent its spread.

These are the findings of a study, researchers from the Centre for Health Science, Queen Mary´s School of Medicine and Dentistry, London did on 50 general practices in Hackney, East London, UK to promote screening for tuberculosis in primary care. The practices were divided into two groups of 25: intervention and control.
 
The researchers found that detection rates for active tuberculosis in intervention practices were 13% higher than those in the control group, while detection rates for the latent form of the disease were also 10 % higher in the practices with the screening programme. The rates of BCG vaccination against tuberculosis were seven times higher for the practices implementing screening against the control group. All in all a seven-fold increase in BCG coverage in people aged five and over represents a striking improvement, since most interventions boost immunisation in primary care by five to 20 %.
 
Hackney was selected as it is one of the areas where tuberculosis is defined as common (more than 40 per 100,000 inhabitants are affected) due to high numbers of migrants from Africa and Eastern Europe, countries which have a spot of multi-drug resistant tuberculosis.
 
The conclusion of the authors is, that screening could have a clinically important effect, and could be recommended as part of tuberculosis control initiatives in industrialised countries.
 
The article was first published in the Lancet, http://www.thelancet.com/

This article was published on 05/14/2007

Search

 

Service

Company News

Products redesigned to help patients simplify life with diabetes

Bayer HealthCare Diabetes Care unveiled the new
CONTOUR® blood glucose meter with enhanced testing features at the 44th Annual Meeting of the European Association for the Study of Diabetes in Rome, Italy.

Carestream: technical infrastructure for EU funded R-bay project

Carestream Health is a major technical infrastructure provider to the EU-funded R-Bay validation project, which aims to address the uneven spread of radiologists across member states. CARESTREAM Radiology and Information Management Solutions are driving the initial test platform for the project by facilitating remote reporting of images from hospitals in Denmark, Finland and Czech Republic by clinical providers in Estonia, Lithuania and the Netherlands.

Accu-Chek® Combo – put effective diabetes management into action

At the annual congress of the European Association for the Study of Diabetes (EASD) this year in Rome, Roche Diabetes Care introduced Accu-Chek Combo – the insulin pump system that combines an insulin pump with an intelligent glucose monitoring system, a bolus calculator, and an integrated pump remote-control.